In situ detection of virus- and tumor-specific T-cell immunity

被引：64
作者：
Haanen, JBAG
Van Oijen, MGCT
Tirion, F
Oomen, LCJM
Kruisbeek, AM
Vyth-Dreese, FA
Schumacher, TNM
机构：
[1] Netherlands Canc Inst, Dept Immunol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Cell Biol, NL-1066 CX Amsterdam, Netherlands
来源：
NATURE MEDICINE | 2000年 / 6卷 / 09期
关键词：
D O I：
10.1038/79573
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：1056 / 1060
页数：5
相关论文
共 50 条
[21]   Tumor-Specific T-cell Help Is Associated with Improved Survival in Melanoma [J].
Woods, Katherine ;
Cebon, Jonathan .
CLINICAL CANCER RESEARCH, 2013, 19 (15) :4021-4023
[22]   Therapeutic vaccine strategies to induce tumor-specific T-cell responses [J].
Ana Marcu ;
Matthias Eyrich .
Bone Marrow Transplantation, 2019, 54 :806-809
[23]   SINGLE-CHAIN T-CELL RECEPTOR AS A TUMOR-SPECIFIC VACCINE [J].
WONG, CP ;
OKADA, CY ;
LEVY, R .
FASEB JOURNAL, 1995, 9 (03) :A514-A514
[24]   Tumor-specific delivery of biologics by a novel T-cell line HOZOT [J].
Teppei Onishi ;
Hiroshi Tazawa ;
Yuuri Hashimoto ;
Makoto Takeuchi ;
Takeshi Otani ;
Shuji Nakamura ;
Fuminori Sakurai ;
Hiroyuki Mizuguchi ;
Hiroyuki Kishimoto ;
Yuzo Umeda ;
Yasuhiro Shirakawa ;
Yasuo Urata ;
Shunsuke Kagawa ;
Toshiyoshi Fujiwara .
Scientific Reports, 6
[25]   Tumor-specific delivery of biologics by a novel T-cell line HOZOT [J].
Onishi, Teppei ;
Tazawa, Hiroshi ;
Hashimoto, Yuuri ;
Takeuchi, Makoto ;
Otani, Takeshi ;
Nakamura, Shuji ;
Sakurai, Fuminori ;
Mizuguchi, Hiroyuki ;
Kishimoto, Hiroyuki ;
Umeda, Yuzo ;
Shirakawa, Yasuhiro ;
Urata, Yasuo ;
Kagawa, Shunsuke ;
Fujiwara, Toshiyoshi .
SCIENTIFIC REPORTS, 2016, 6
[26]   Therapeutic vaccine strategies to induce tumor-specific T-cell responses [J].
Marcu, Ana ;
Eyrich, Matthias .
BONE MARROW TRANSPLANTATION, 2019, 54 (Suppl 2) :806-809
[27]   IMPLICATIONS OF LEUKOREGULIN TO AUTOLOGOUS TUMOR-SPECIFIC HUMAN T-CELL POPULATIONS [J].
SLINGLUFF, CL ;
SEIGLER, HF ;
DARROW, TL ;
EVANS, CH .
JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (04) :387-394
[28]   Priming or tolerization of tumor-specific T cell immunity; Lessons from murine tumor models [J].
Offringa, R ;
Toes, REM ;
Schoenberger, SP ;
Melief, CJM .
SPECIFIC IMMUNOTHERAPY OF CHRONIC AUTOIMMUNE DISEASES: HOW TO TRANSLATE THE EXPERIENCE OF THE EXPERIMENTAL MODELS INTO NOVEL TREATMENT MODALITIES, 1999, :41-49
[29]   CELL-SURFACE MODIFICATION OF TUMOR-CELL BY NEWCASTLE-DISEASE VIRUS LEADS TO AUGMENTED TUMOR-SPECIFIC T-CELL RESPONSES [J].
SCHIRRMACHER, V ;
VONHOGEN, P ;
SCHILD, H .
CANCER AND METASTASIS REVIEWS, 1989, 8 (02) :171-172
[30]   TUMOR-SPECIFIC CELLULAR IMMUNITY [J].
COHEN, AM ;
BURDICK, JF ;
KETCHAM, AS .
JOURNAL OF SURGICAL RESEARCH, 1971, 11 (08) :421-+
12345